MAXCYTE, INC.

Maxcyte, Inc.

Medical Devices • Healthcare • Rockville, MD, United States • MXCT (NMS)

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

301 944 1700 9713 Key West Avenue, Rockville, MD 20850, United States

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

$MXCT stock is up 12% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitative • Sep 23
Earnings call transcript: MaxCyte Q3 2025 misses forecasts, stock dips - Investing.com
Investing.com • Nov 12
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
MarketBeat • Dec 17
MaxCyte (NASDAQ: MXCT) begins CFO succession search, transition in first half 2026 - Stock Titan
Stock Titan • Nov 12
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio - Yahoo Finance
Yahoo Finance • Aug 11

Other Medical Devices Companies

View All →
ABBOTT LABORATORIES logo Abbott Laboratories
$218.91B market cap
BOSTON SCIENTIFIC CORP logo Boston Scientific Corp.
$142.40B market cap
STRYKER CORP logo Stryker Corp.
$135.46B market cap
Medtronic plc logo Medtronic PLC
$123.80B market cap
Edwards Lifesciences Corp logo Edwards Lifesciences Corp.
$51.04B market cap
DEXCOM INC logo Dexcom Inc.
$26.50B market cap

Frequently Asked Questions

Has MAXCYTE, INC. had layoffs?
No layoff events have been recorded for MAXCYTE, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does MAXCYTE, INC. have?
MAXCYTE, INC. has approximately 114 employees.
What industry is MAXCYTE, INC. in?
MAXCYTE, INC. operates in the Medical Devices industry, within the Healthcare sector.
Is MAXCYTE, INC. a publicly traded company?
Yes, MAXCYTE, INC. is publicly traded under the ticker symbol MXCT on the NMS. The company has a market capitalization of approximately $0.17 billion.
Where is MAXCYTE, INC. headquartered?
MAXCYTE, INC. is headquartered in Rockville, MD, United States at 9713 Key West Avenue, Rockville, MD 20850, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.